Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies
Authors
Keywords
Antigens, Vaccines, Antibodies, Glycosylation, HEK 293 cells, CHO cells, Cell binding, Monoclonal antibodies
Journal
PLoS One
Volume 13, Issue 4, Pages e0196370
Publisher
Public Library of Science (PLoS)
Online
2018-04-25
DOI
10.1371/journal.pone.0196370
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of UNAIDS targets and HIV vaccination across 127 countries
- (2017) Jan Medlock et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail
- (2017) Boris Julg et al. Science Translational Medicine
- New concepts in HIV-1 vaccine development
- (2016) Kathryn E Stephenson et al. CURRENT OPINION IN IMMUNOLOGY
- Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies
- (2016) Stefanie A. Krumm et al. Retrovirology
- HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies
- (2016) Steven W. de Taeye et al. TRENDS IN IMMUNOLOGY
- Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
- (2015) Jason Gorman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies
- (2015) Laura K. Pritchard et al. Nature Communications
- Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
- (2015) Jason Gorman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers
- (2015) Laura K. Pritchard et al. Cell Reports
- Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
- (2014) Ariel Halper-Stromberg et al. CELL
- HIV-1 Envelope Proteins and V1/V2 Domain Scaffolds with Mannose-5 to Improve the Magnitude and Quality of Protective Antibody Responses to HIV-1
- (2014) Javier F. Morales et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
- (2014) Jinghe Huang et al. NATURE
- Proof of principle for epitope-focused vaccine design
- (2014) Bruno E. Correia et al. NATURE
- Novel vaccine vectors for HIV-1
- (2014) Dan H. Barouch et al. NATURE REVIEWS MICROBIOLOGY
- Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
- (2014) Susan Zolla-Pazner et al. PLoS One
- Transplanting Supersites of HIV-1 Vulnerability
- (2014) Tongqing Zhou et al. PLoS One
- Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
- (2014) N. L. Yates et al. Science Translational Medicine
- Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV
- (2014) D. Sok et al. Science Translational Medicine
- Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike
- (2014) Louise Scharf et al. Cell Reports
- Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
- (2013) Masashi Shingai et al. NATURE
- Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
- (2013) Leopold Kong et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function
- (2013) Marie Pancera et al. PLoS One
- Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
- (2013) Raphael Gottardo et al. PLoS One
- Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
- (2013) J.-P. Julien et al. SCIENCE
- Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
- (2013) J. Jardine et al. SCIENCE
- Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
- (2013) Sam Hoot et al. PLoS Pathogens
- Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans
- (2013) Jean-Philippe Julien et al. PLoS Pathogens
- Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data
- (2012) M. Kearse et al. BIOINFORMATICS
- Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
- (2012) M. Bonsignori et al. JOURNAL OF VIROLOGY
- Glycan-Dependent Immunogenicity of Recombinant Soluble Trimeric Hemagglutinin
- (2012) R. P. de Vries et al. JOURNAL OF VIROLOGY
- Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
- (2012) Morgane Rolland et al. NATURE
- Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
- (2012) Jinghe Huang et al. NATURE
- HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
- (2012) Florian Klein et al. NATURE
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycoform and Net Charge Heterogeneity in gp120 Immunogens Used in HIV Vaccine Trials
- (2012) Bin Yu et al. PLoS One
- Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
- (2012) H. Mouquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Occluding the Mannose Moieties on Human Immunodeficiency Virus Type 1 gp120 with Griffithsin Improves the Antibody Responses to Both Proteins in Mice
- (2011) Kaustuv Banerjee et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
- (2011) M. Bonsignori et al. JOURNAL OF VIROLOGY
- Enzyme Digests Eliminate Nonfunctional Env from HIV-1 Particle Surfaces, Leaving Native Env Trimers Intact and Viral Infectivity Unaffected
- (2011) E. T. Crooks et al. JOURNAL OF VIROLOGY
- Broad neutralization coverage of HIV by multiple highly potent antibodies
- (2011) Laura M. Walker et al. NATURE
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
- (2011) R. Pejchal et al. SCIENCE
- Glycosylation Patterns of HIV-1 gp120 Depend on the Type of Expressing Cells and Affect Antibody Recognition
- (2010) Milan Raska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression-System-Dependent Modulation of HIV-1 Envelope Glycoprotein Antigenicity and Immunogenicity
- (2010) Leopold Kong et al. JOURNAL OF MOLECULAR BIOLOGY
- Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
- (2010) K. J. Doores et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
- (2010) T. Zhou et al. SCIENCE
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
- (2010) X. Wu et al. SCIENCE
- CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions
- (2009) Lars Nitschke IMMUNOLOGICAL REVIEWS
- Protease Cleavage Sites in HIV-1 gp120 Recognized by Antigen Processing Enzymes Are Conserved and Located at Receptor Binding Sites
- (2009) B. Yu et al. JOURNAL OF VIROLOGY
- Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
- (2009) L. M. Walker et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started